MedTrace Logo

Serological Screening of Gastric Cancer in Wuxi Region

NCT02663427 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5000

Last updated 2016-01-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether detection of pepsinogen Ⅰand Ⅱ combined with Helicobacter pylori antibody, so-called ABC method , is fit on gastric cancer screening in community of Wuxi City.

Conditions

  • Stomach Neoplasms

Interventions

DEVICE

serological examination and gastroscope

Sponsors & Collaborators

  • Jiangsu Institute of Nuclear Medicine

    collaborator OTHER

  • Wuxi People's Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-01-31
Completion
2018-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02663427 on ClinicalTrials.gov